Great News for Stem Cell Believers

9:05AM Geron: BioTime (BTX) issues open letter to shareholders of Geron; proposes transaction between Biotime Acquisition and Geron (GERN) 1.42 : BioTime (BTX) issued a letter to the shareholders of Geron regarding Geron's stem cell assets. BTX proposes Geron shareholders could own up to 45% of a new publicly traded co that will own the Geron stem cell assets, $40 mln of BioTime stock, certain BioTime stem cell assets, and shares of certain BioTime stem cell subsidiaries. Geron shareholders would also receive BioTime stock-purchase warrants presently valued at ~$13 mln. Geron would retain its cancer therapy business, including Imetelstat and GRN1005, and its cash and short-term liquid investments and Geron shareholders would continue to own 100% of the Geron cancer therapy business through their ownership of Geron stock. Through the "Stem Cell Transaction", Geron would transfer its stem cell assets to BioTime Acq, in exchange for which you along with the other Geron shareholders would receive shares of BAC common stock representing ~21.4% of the outstanding BAC capital stock. BioTime would contribute to BAC the following assets in exchange for the balance of outstanding BAC capital stock: $40 mln in BioTime common shares; Warrants to purchase BioTime common shares; Rights to certain stem cell assets of BioTime, and shares of two BioTime subsidiaries engaged in the development of therapeutic products from stem cells. .............................................................................................................................................................................................................................................................. This is all Geron is going to get. I'm going to take it. I believe in the science. I hope BioTime restarts the Phase 1 trials on spinal injuries soon. Just hope I live long enough to see results. Geron is up over $1.51. BTX was up a penny................ Good luck in this rigged casino,